Jiangxi Rimag Group (HKG:2522) is looking to raise net proceeds of up to HK$182.3 million from the placement of 9,750,000 shares to at least six investors at HK$20 apiece, a Friday filing with the Hong Kong bourse said.
The shares represent approximately 3.76% of issued H shares and 2.66% of the total number of issued shares as enlarged by the issue.
The medical imaging solution services company will use proceeds from the issue for business investment and mergers and acquisitions, overseas business expansion, data and R&D, and general working capital.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。